0 Trusted Subscribers
0 Tenders Listed
Daily Updates
Supply of Various Medicines and Eye Drops by Directorate General Procurement (Army) Rawalpindi
Tender No: 26B-1233-FY26-27-02-C-MED
Active Tender
Closing Date:
2026-10-28
2026-10-28
Tender Overview
- Category
- Medical & Surgical Supplies
- Sector
- Goods
- Tender Type
- Goods
- Submission Method
- Sealed bids to be submitted in the Tender Room of Directorate General Procurement (Army) Rawalpindi by 0930 hrs on opening date
- Source Name
- Newspaper
Location & Dates
- City
- Rawalpindi
- Province
- Punjab
- Country
- Pakistan
- Publish Date
- 2026-10-17
- Closing Date
- 2026-10-28
- Created At
- 2026-10-17 04:49:12
Contact & Websites
- Contact Phone
- 051-9281603
- Website
- www.ppra.org.pk
Actions
Download Tender Document
Back to All Tenders
Looking for more tenders like this? View all active Medical & Surgical Supplies tenders.
Related Tenders
Purchase of Science Lab Equipment, Networking Items, Printers, Scanner, Surveillance Equipment and...
Close: 2026-11-09 Nankana Sahib, Punjab
Supply of LP Medicine, Surgical Disposable Items and General Store Items for...
Close: 2026-11-09 Faisalabad, Punjab
Procurement of Dialysis Machines and Laboratory Items
Close: 2026-11-10 Kamra, Punjab
Provision of Prescribed Medicines to Federal Government Employees Housing Authority Islamabad
Close: 2026-11-10 Islamabad, Islamabad Capital Territory
Procurement of Medical Equipment for Peshawar Institute of Cardiology
Close: 2026-11-12 Peshawar, Khyber Pakhtunkhwa
Supply of Immunohistochemistry (IHC) Markers for Pathology Department
Close: 2026-11-12 Abbottabad, Khyber Pakhtunkhwa
Tender Document

Tender Description
The Directorate General Procurement (Army) Rawalpindi invites sealed tenders from reputed firms possessing NTN certificates for the supply of various medicines and eye drops. This procurement is conducted under PPRA rules with an emphasis on avoiding exorbitant rates.
Items being procured:
- Levosulpride 50 mg Tab (1003140 Nos)
- Ceftriaxone Sodium Inj 500 mg with water for Inj (58830 VL + 1750 Nos)
- Levosulpride 25 mg Tab (1083600 Nos + 72000 Nos)
- Levetiracetam 500 mg Tab (2911640 Nos + 31200 Nos)
- Fluoromethalone 0.1% + Tetrahydrozoline 0.25% Eye Drops Bot 5 ml (45350 Btl + 4000 Nos)
- Sodium Valproate Tab 500 mg (2564992 Nos + 180000 Nos)
- Polyvinyl Alcohol 1.4% + Povidone 0.6% Eye Drops Bot 10 ml (195220 Btl + 40000 Nos)
- Amino Acid Infusion 500 ml Inj (25800 VL + 700 Nos)
- Iofexol (Ultravist/Omnipaque) 350mg/ml, bottle of 100 ml Inj (18100 Nos + 57800 Nos)
- Zinc 22.5 mg, VIT-E 31 IU, C500 mg, Folic Acid 150 mcg, B-1 15 mg, B-2 15 mg, B-6 20mg, B-12 12 mcg, Nicotinamide 100 mg, Pantothenic Acid 20 mg Tab (113902 VL + 1st Sep 2027 to 1st Apr 2028 Nos)
- Diclofenac Sodium + Misoprotol Tab 50/0.2 mg (1154180 Nos + 72350 Nos)
- Budesonide 200 mcg + Formoterol (Fumarate) 6 mcg rotacaps (100360 Nos)
- Ivabradine 5 mg Tab (337270 Nos + 250000 Nos)
- Gemecitabine 200 mg Inj (6600 VL)
- Pipercacillin & Tazobactam Inj 4.5 gm with Water For Inj (78430 VL + 9290 Nos)
- Tamsulosin 0.4 mg + Dutasteride 0.5 mg Cap (1677940 Nos + 1323700 Nos)
- Naphazoline HCL 0.025% to 0.050% with Suitable salts and preservatives Eye Drops 15 ml (109140 Btl + 300 Nos)
- Terlipersin 1 mg with water for Inj (8900 VL)
- Eltrombopag Olamine 50 mg Tab (10000 Nos)
- Dexamethasone 0.1% + Tobramycin 0.3% EYE Drops Bot of 5 ml (111990 Btl + 18030 Nos)
- Inj Busulphan 60mg (350 VL)
- Telmisartan + Amlodipine 5/80 mg Tab (425500 Nos + 40500 Nos)
- Betamethasone Valerate 0.1% Cream tube of 15 GM (143100 Tub)
- Mag Venetecol 100 MG (3100 Nos + 1800 Nos)
- Beclomethasone Dipropionate 800 MCG Solution (492612 VL + 37300 Nos)
- Haematic/Vitamin Tab (14251300 Nos + 79000 Nos)
- Methyldopa 250 mg Tab (417540 Nos)
- Pippracillin & Tazobactam Inj 2.25 gm with Water For Inj (20600 VL + 1500 Nos)
- Ruxolitinib 5mg tab (10000 Nos)
The technical scope covers supply of pharmaceutical products including tablets, injections, eye drops, creams, and capsules as per specifications. Delivery periods vary with last dates mostly by 23rd October 2026 and opening dates from 27th October 2026 onwards at 1000 hrs.
Eligibility criteria include valid NTN certificates, registration letters with DGDP and MoH, drug manufacturing license by DRAP, export/import license for foreign firms, financial capability proof, valid sales tax registration, and provision of certificates regarding market share data.
Earnest Money Deposit (Bid Security) is required as per quoted value with different percentages for pre-qualified, registered, un-registered firms. Payment of PKR 2000 for tender documents is to be deposited in Government Treasury.
Bids must be submitted in sealed envelopes marked with Tender Enquiry number by 0930 hrs on opening date at the Tender Room of DGP (Army). Technical offer, Earnest Money Draft, and Commercial Offer should be submitted separately.
For interested bidders, it is practical to ensure all registration and licensing documents are up to date and to prepare earnest money drafts in advance to avoid last-minute delays. Early submission is advised to avoid disqualification.
Contact details for further information are Tel No. 051-9281603 and Fax No. 051-9280909. The official website is www.ppra.org.pk.
